Freestone Capital Holdings, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1470876 Seattle, WA

Position in VRTX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$498,716

+$96,830 QoQ

Shares Held

1,004

+11.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,080

of 1,746 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Freestone Capital Holdings, LLC holds $7,262,289 across 14 Biotechnology names. VRTX ranks #5 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABUS	Arbutus Biopharma Corp	442,500	$2,124,000
2	IMNM	Immunome Inc.	60,589	$1,283,880
3	BNTX	BioNTech SE	7,914	$736,397
4	REGN	Regeneron Pharmaceuticals, Inc.	904	$563,680
5	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,004	$498,716
6	RYTM	Rhythm Pharmaceuticals, Inc.	3,700	$410,811
7	RVMD	Revolution Medicines, Inc.	2,109	$394,973
8	EXEL	Exelixis, Inc.	6,974	$379,455

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$498,716	1,004	+11.6%	Shares	Defined	2026-07-31
2026-03-31	$401,886	900	+6.0%	Shares	Defined	2026-05-13
2025-12-31	$384,902	849	-6.9%	Shares	Defined	2026-01-23
2025-09-30	$357,175	912	-10.2%	Shares	Defined	2025-11-12
2022-06-30	$286,298	1,016	-28.1%	Shares	Defined	2022-08-09
2022-03-31	$368,750	1,413	-3.0%	Shares	Defined	2022-05-12
2021-12-31	$319,737	1,456	+17.0%	Shares	Defined	2022-02-14
2021-06-30	$250,827	1,244	-3.0%	Shares	Defined	2021-08-16
2021-03-31	$275,488	1,282	+34.1%	Shares	Defined	2021-05-17
2020-12-31	$225,941	956	+32.4%	Shares	Defined	2021-02-16
2020-09-30	$196,470	722	—	Shares	Defined	2020-11-06
No filing history on record for this holder in this stock.